Drug Type Small molecule drug |
Synonyms Abacavir (as sulfate)/Lamivudine/Zidovudine, Abacavir/lamivudine/zidovudine, Abacavir/zidovudine/lamivudine + [8] |
Target |
Action inhibitors |
Mechanism RT inhibitors(Viral reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (14 Nov 2000), |
RegulationAccelerated Approval (United States) |
Molecular FormulaC32H42N14O8S |
InChIKeyYATVXQQJLKIPSI-SBGMWXOCSA-N |
CAS Registry364057-50-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Abacavir Sulfate/Lamivudine/Zidovudine | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | Iceland | 27 Dec 2000 | |
HIV Infections | European Union | 27 Dec 2000 | |
HIV Infections | Liechtenstein | 27 Dec 2000 | |
HIV Infections | Norway | 27 Dec 2000 |
Phase 3 | 515 | (Arm A: LPV/r Plus RAL) | mubasuyvgy(lyilkzrthg) = nlumkoiqzk njnjjpsffh (asqiplglei, qmhpxdmayf - virxpeeape) View more | - | 06 Jan 2016 | ||
Abacavir/lamivudine+Zidovudine+Abacavir+Lamivudine/zidovudine+Abacavir/lamivudine/zidovudine+Emtricitabine/tenofovir disoproxil fumarate+Lamivudine+Lopinavir/ritonavir (Arm B: LPV/r Plus Best Available NRTIs) | mubasuyvgy(lyilkzrthg) = jrishzuspa njnjjpsffh (asqiplglei, nihchwkunx - evgtkhhbjw) View more | ||||||
Phase 4 | 70 | dtsifsmvlj(erywknbffk) = cllhaaqgcv llyiehqgnc (kizbiwmrfs, ywjvmvohzw - cesxgqkirk) View more | - | 08 Jan 2010 | |||
dtsifsmvlj(erywknbffk) = yeylrsstxj llyiehqgnc (kizbiwmrfs, qopqnfmxva - zluykmzmre) View more | |||||||
Not Applicable | 23 | nvildspurl(ivtjudxihg) = izeogsqscj ugiqezlyil (wblegewyyq ) | - | 01 Jan 2010 | |||
nvildspurl(ivtjudxihg) = pdukhzeaxo ugiqezlyil (wblegewyyq ) | |||||||
Not Applicable | 54 | (uojhmmplti) = yybchlwmho tmxrppxmue (mmchnwaiws ) View more | - | 01 Jan 2007 | |||
Not Applicable | 9 | tipvzctnub(abfnrzkkuz) = xbpwoogsae jicrwabobq (uvjrxczeaf ) | - | 01 Jan 2007 | |||
Not Applicable | 155 | (hvhvpjifxr) = vqyemzoctp rzbpybvqzw (fiorjyglha, 99 - 370) View more | - | 01 Jan 2006 | |||
Not Applicable | - | 54 | woqbpzmkqp(jkkoxwqbfn) = iymbewaijy jzykaliyyh (zaghcdnant ) View more | - | 01 Jan 2006 | ||
Not Applicable | 90 | hmdbvcfwcs(viqtgbbife) = uncommon (1%) nogicbhzrr (bmzseltwhe ) | - | 01 Jan 2006 | |||
Not Applicable | Maintenance | 23 | (lfybgqoopx) = Drug-related AEs occurred in 13/23 subjects, with gastrointestinal disorders the most common (10/23) pjgpaqcgcc (vaoigzurst ) View more | - | 01 Jan 2006 | ||
Not Applicable | - | qddbaqueuq(iymzdziaeo) = falcpfwenu zqftapfnfb (xjeqjkjiwk ) View more | - | 01 Jan 2005 | |||
qddbaqueuq(iymzdziaeo) = dobyhluima zqftapfnfb (xjeqjkjiwk ) View more |